Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 17 Colonic Neoplasms 15 Rectal Neoplasms 11 Stomach Neoplasms 10 Ovarian Neoplasms 6 Neoplasms 5 Gastrointestinal Stromal Tumors 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Neoplastic Cells, Circulating 2 Kidney Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Venous Thrombosis 1 Uterine Neoplasms 1 Surgical Wound Infection 1 Robotic 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1 Ornithine Carbamoyltransferase Deficiency Disease 1 Obesity, Morbid 1 Neurologic Manifestations 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 37 Gemcitabine 29 Nivolumab 20 Cisplatin 19 atezolizumab 15 avelumab 14 Docetaxel 13 enfortumab vedotin 10 Carboplatin 10 durvalumab 9 Magnetic Resonance Spectroscopy 9 Ipilimumab 8 Paclitaxel 7 Pemetrexed 6 toripalimab 5 cabozantinib 5 Fluorodeoxyglucose F18 5 sacituzumab govitecan 4 cabazitaxel 4 Taxes 4 vinflunine 3 tremelimumab 3 pemigatinib 3 X-Rays 3 Standard of Care 3 Specimen Handling 3 Radiotherapy 3 Mitomycin 3 Immunotherapy 3 Immunoglobulin G 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Transitional Cell × Laparoscopy × Clear all

NCT03677544 2023-05-17

CYSTECTOMEN

Centre Hospitalier Universitaire, Amiens

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡